Best results of angioplasty with DES guided by IVUS versus angiography only

Original title: Intravascular Ultrasound-Guided Implantation of Drug-Eluting Stents to Improve Outcome. A Meta-Analysis. Reference: Jae-Sik Jang et al. J Am Coll Cardiol Intv 2014, epub ahead of print.

Several previous studies and meta-analysis showed that implantation of conventional stents (BMS) intravascular ultrasound (IVUS) guided may decrease restenosis and clinical events. This information was not yet clear to drug-eluting stents.

This meta- analysis included 15 studies (3 randomized and 12 observational) with 24849 patients, 11793 received IVUS-guided angioplasty and 13056 guided by angiography. IVUS-guided angioplasty showed a significantly lower rate of death from any cause (OR 0.64, CI 95% 0.51 to 0.81, P < 0.001), acute myocardial infarction (OR 0.57, CI 95% 0.42 to 0.78, P < 0.001) and target vessel revascularization (OR 0.81, CI 95% CI 0.68 to 0.95, P = 0.01). IVUS -guided angioplasty was also associated with significantly less definite or probable thrombosis (OR 0.59, CI 95% 0.42 to 0.82, P = 0.002). Overall, IVUS decreased by 21% the risk of combined events and 36% the risk of death compared with angioplasty guided by angiography alone. In the stratified analysis, according to study design a lower incidence of events in non- randomized studies was observed (OR 0.81; CI 95% 0.68 to 0.96, p = 0.02) compared with randomized studies. In fact the latter only showed a trend in favor of IVUS versus angiography (OR 0.69, CI 95% 0.46 to 1.04, P = 0.07). 

Conclusion

This meta-analysis showed that angioplasty with drug-eluting stents guided by IVUS reduces clinical events compared with angiographic guidance only. Additional trials with adequate statistical power to identify patients or lesions with different risk profiles that may especially benefit from this technique are need it. 

Editorial comment

The advantage of IVUS in this work seems to be related to a lower incidence of heart attack or death rather than decreased angiographic restenosis and repeat revascularization rate. The mechanism is related to the ability of IVUS to identify factors associated with peri-procedural complications such as dissection or hematoma at the edges, sub-expansion or incomplete stent apposition.

SOLACI.ORG

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....